Brian O Mahony/X
Jun 24, 2025, 22:08
Rewriting Your DNA in Childhood: Because Why Wait to Cure Hemophilia? | ISTH 2025 Breakthrough
Ben Samelson-Jones, Assistant Professor of Pediatrics at University of Pennsylvania School of Medicine, posted on X:
”Sustained and stable FIX levels have now been repeatedly been observed across multiple #genetherapy clinical trials for Hemophila B. Will extend the red line tomorrow at Clinical Gene Therapy session at ISTH2025.”
Reposting from Brian O Mahony, CEO of the Irish Haemophilia Society and former President of both the WFH and EHC, sharing bold new advances in haemophilia management presented at ISTH 2025 via X:
”FIX expression and durability compared between clinical trials. Malec, ISTH2025.”
Gene Editing: Welcome to a New World!
A shot and you are done with Hemophilia B?

Don’t miss the new updates with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp
